Immunic (IMUX) vs Quantum Cyber N.V. (QUCY)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Quantum Cyber N.V. (QUCY) has outperformed Immunic (IMUX) over the past year, losing 13.1% versus a loss of 15.8%. Quantum Cyber N.V. is the larger company by market cap ($116.9 million vs $110.4 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | IMUX | QUCY |
|---|---|---|
| Share price | $8.09 | $1.39 |
| Market cap | $110.38M | $116.85M |
| 1-day change | +7.01% | 0.00% |
| YTD return | +41.57% | +24.11% |
| 1-year return | -15.81% | -13.13% |
| 5-year return | -91.28% | — |
| EPS (TTM) | $-3.83 | $-2.41 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $17.43 | $4.93 |
| 52-week low | $5.06 | $0.30 |
| Distance from 52-week high | -53.59% | -71.81% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +432.63% | +547.48% |
| Average volume | 284.68K | 691.24K |
| Shares outstanding | 13.64M | 84.07M |
| Employees | 100 | 10 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Immunic
IMUX stock →Immunic, Inc., a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany. Its lead development program is IMU-838, which is in Phase 3 clinical and phase 2 clinical development for patients with relapsing and progressive multiple sclerosis; and moderate-to-severe ulcerative colitis.
Health Care · Biotechnology: Pharmaceutical Preparations · 100 employees
About Quantum Cyber N.V.
QUCY stock →Quantum Cyber N.V. operates as a technology company focused on cybersecurity and quantum computing solutions.
Health Care · Biotechnology: Pharmaceutical Preparations · 10 employees
IMUX vs QUCY FAQ
Which is bigger, Immunic or Quantum Cyber N.V.?
Quantum Cyber N.V. (QUCY) is larger, with a market capitalization of $116.85M compared with $110.38M for Immunic (IMUX).
Which stock has performed better over the past year, IMUX or QUCY?
QUCY returned -13.13% over the past 12 months, compared with -15.81% for IMUX (price return, excluding dividends). Past performance does not predict future results.
Are Immunic and Quantum Cyber N.V. in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.